...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith Updates
1
Jan 29, 2016 10:52AM
6
Jan 29, 2016 12:50PM
5
Jan 30, 2016 10:49AM
5
Jan 30, 2016 11:14AM
5
Jan 30, 2016 01:05PM
7
Feb 02, 2016 02:53PM
3
Feb 02, 2016 07:02PM
3
Feb 02, 2016 07:40PM
6
Feb 02, 2016 10:41PM
4
Feb 03, 2016 08:41AM

Feb 03, 2016 09:08AM
3
Feb 03, 2016 11:09AM

Interesting to see this event listed on Zenith's event page:

12th Annual BIOTECanada Investor Summit

February 26-28, 2016

Whistler, BC, Canada

The BIOTECanada Investor Summit presents a unique and timely opportunity for investors, commercial partners and pre-commercial companies to connect, network and explore investment/partnership opportunities within the Canadian biotech industry. Each year ten emerging companies in search of investment capital are provided the opportunity to present their company and therapy to the investors and pharma partners.

Share
New Message
Please login to post a reply